MPM Asset Management’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-12,324
Closed -$2.66M 6
2019
Q1
$2.66M Hold
12,324
1.1% 6
2018
Q4
$4.26M Hold
12,324
3.61% 4
2018
Q3
$14.3M Hold
12,324
9.68% 4
2018
Q2
$10.5M Hold
12,324
4.09% 4
2018
Q1
$14.5M Buy
12,324
+1,818
+17% +$2.01M 5.57% 4
2017
Q4
$9.71M Buy
10,506
+4,546
+76% +$4.2M 3.89% 5
2017
Q3
$6.54M Hold
5,960
3.19% 4
2017
Q2
$6.87M Hold
5,960
2.98% 4
2017
Q1
$6.88M Hold
5,960
3.31% 5
2016
Q4
$6.28M Hold
5,960
2.97% 6
2016
Q3
$2.38M Hold
5,960
0.78% 7
2016
Q2
$2.46M Hold
5,960
0.8% 9
2016
Q1
$2.55M Hold
5,960
0.79% 9
2015
Q4
$3.43M Hold
5,960
0.61% 9
2015
Q3
$5.3M Hold
5,960
0.82% 10
2015
Q2
$6.14M Hold
5,960
1.03% 10
2015
Q1
$8.49M Hold
5,960
1.81% 10
2014
Q4
$8.35M Hold
5,960
1.85% 10
2014
Q3
$7.3M Hold
5,960
2.39% 8
2014
Q2
$10.9M Hold
5,960
3.65% 7
2014
Q1
$9.7M Hold
5,960
4.11% 7
2013
Q4
$7.69M Hold
5,960
2.48% 8
2013
Q3
$12M Buy
+5,960
New +$11.1M 3.38% 7

Other funds holding HSTO

MPM Asset Management's HSTO Position: Q2 2019 in Review

MPM Asset Management sold out of Histogen Inc. Common Stock (HSTO) in Q2 2019, closing a stake of 12,324 shares — an estimated $2.66M sold.

MPM Asset Management first reported a position in HSTO in Q3 2013 and held it in 23 quarters. The position peaked at $14.5M in Q1 2018. 36 funds tracked by Wall St. Rank hold HSTO as of Q2 2019.

  • MPM Asset Management reported no remaining Histogen Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • MPM Asset Management sold 12,324 Histogen Inc. Common Stock shares in Q2 2019, an estimated $2.66M.
  • MPM Asset Management first reported a position in Histogen Inc. Common Stock in Q3 2013 and held it in 23 quarters.
  • MPM Asset Management's Histogen Inc. Common Stock position peaked at $14.5M in Q1 2018.
  • 36 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2019.

Based on MPM Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.